- Home
- NCNA vs ISPC Comparison
NCNA vs ISPC Comparison
Compare NCNA & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- ISPC
- Stock Information
- Founded
- NCNA 1997
- ISPC 2009
- Country
- NCNA United Kingdom
- ISPC United States
- Employees
- NCNA N/A
- ISPC N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- NCNA Health Care
- ISPC Health Care
- Exchange
- NCNA Nasdaq
- ISPC Nasdaq
- Market Cap
- NCNA 7.6M
- ISPC 6.9M
- IPO Year
- NCNA 2017
- ISPC 2021
- Fundamental
- Price
- NCNA $3.63
- ISPC $0.65
- Analyst Decision
- NCNA
- ISPC
- Analyst Count
- NCNA 0
- ISPC 0
- Target Price
- NCNA N/A
- ISPC N/A
- AVG Volume (30 Days)
- NCNA 324.2K
- ISPC 422.1K
- Earning Date
- NCNA 11-24-2025
- ISPC 11-14-2025
- Dividend Yield
- NCNA N/A
- ISPC N/A
- EPS Growth
- NCNA N/A
- ISPC N/A
- EPS
- NCNA N/A
- ISPC N/A
- Revenue
- NCNA N/A
- ISPC $5,908,088.00
- Revenue This Year
- NCNA N/A
- ISPC $35.93
- Revenue Next Year
- NCNA N/A
- ISPC N/A
- P/E Ratio
- NCNA N/A
- ISPC N/A
- Revenue Growth
- NCNA N/A
- ISPC N/A
- 52 Week Low
- NCNA $2.78
- ISPC $0.64
- 52 Week High
- NCNA $332.00
- ISPC $5.48
- Technical
- Relative Strength Index (RSI)
- NCNA 40.04
- ISPC 34.33
- Support Level
- NCNA $3.71
- ISPC $0.75
- Resistance Level
- NCNA $4.07
- ISPC $0.82
- Average True Range (ATR)
- NCNA 0.35
- ISPC 0.07
- MACD
- NCNA -0.16
- ISPC -0.00
- Stochastic Oscillator
- NCNA 0.98
- ISPC 3.35
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.